Regeneron Pharmaceuticals announced positive three-year results from an extension study of EYLEA HD (aflibercept) Injection 8 mg for treating wet age-related macular degeneration (wAMD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback